NoIR 3% Dark Amber SpectraShield Medium 407-36
by NoIR
Last verified June 19, 2026 · classified April 26, 2026
What it is
Summary
AI-generated from vendor-published content · April 26, 2026
These are high-filtration sunglasses designed for people with severe light sensitivity, blocking 97% of incoming light and providing full UV, blue light, and infrared protection. They're particularly well-suited for someone with a condition like Retinitis Pigmentosa, albinism, or post-surgical photophobia who finds ordinary sunglasses inadequate in bright environments. The SpectraShield frame includes side shields and a top ridge to block light from all angles, and the glasses can be worn directly or fitted over prescription eyewear. 3% light transmission is extremely dark — useful in bright outdoor or fluorescent conditions, but potentially too dim for indoor use or low-light environments.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Medicaid waiver
- Out of pocket
What Setup Looks Like
- Out of the box
- Put on the glasses — they work immediately as worn, either alone or over prescription eyewear.
- The side shields and top ridge provide wraparound coverage without any adjustment needed.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
As an Amazon Associate we earn from qualifying purchases.
How to Fund This
Equipment like this is often pursued through official state programs. These are common starting points — each program decides its own eligibility and what it covers, so the first step is always a phone call.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from NoIR — view on vendor site; last verified June 19, 2026.
Classification & description AI-generated from vendor-published content on April 26, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.